Participants sought: People with COPD for in-home nasal high flow air therapy

Participants with COPD sought for 8 day in-home study

EAGLE is a phase II trial to assess feasibility of using nasal high flow for breathlessness in participants with chronic obstructive pulmonary disease (COPD) who do not qualify for domiciliary long-term oxygen therapy.

We are seeking participants for our 8-day trial of in-home nasal high flow air therapy for COPD patients who experience breathlessness. The study aims to determine the effects of in-home nasal high flow air therapy on breathlessness, quality of life, and other symptom management. 

Contact Dr Amy Pascoe:

• email amy.pascoe@monash.edu 
• phone +61 3 9903 8930
  

Participants sought: SINFONIA: Are there benefits of SingINg For breathing in COPD aNd ILD pAtients (SINFONIA)?

Can singing help your COPD or ILD? Image: Solace Hospice

3 May update: We're happy to announce that the SINFONIA trial is now live with its first session being held Thursday 5 May. Anyone interested please contact Amy Pascoe, see detail below. 

Participants are sought for a clinical trial examining the benefits of SingINg For breathing in COPD aNd ILD pAtient (SINFONIA). It is a 12-week trial of guided online group singing for patients with chronic obstructive pulmonary disease (COPD) or interstitial lung disease (ILD) who experience breathlessness, and (optionally) their carers. 

The study aims to determine the effects of online group singing on well-being and symptom management.

Contact Dr Amy Pascoe:

• email amy.pascoe@monash.edu 
• phone +61 3 9903 8930